MD HB1212 | 2017 | Regular Session

Status

Spectrum: Slight Partisan Bill (Democrat 14-9)
Status: Engrossed on March 20 2017 - 50% progression, died in committee
Action: 2017-04-05 - Hearing 4/05 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Engrossed) [PDF]

Summary

Authorizing specified insurers, nonprofit health service plans, and health maintenance organizations to apply a prior authorization requirement for opioid antagonist drug products only under specified circumstances; applying the Act to all policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or after January 1, 2018; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health Insurance - Prior Authorization for Opioid Antagonists - Authorization

Sponsors


Roll Calls

2017-03-17 - House - House Floor - Third Reading Passed (141-0) (Y: 141 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2017-04-05SenateHearing 4/05 at 1:00 p.m.
2017-03-21SenateFirst Reading Finance
2017-03-20HouseThird Reading Passed (141-0)
2017-03-18HouseSecond Reading Passed with Amendments
2017-03-18HouseFavorable with Amendments {606889/1 Report Adopted
2017-03-17HouseFavorable with Amendments Report by Health and Government Operations
2017-03-13HouseHearing 3/13 at 12:00 p.m.
2017-03-09HouseHearing canceled
2017-03-13HouseHearing 3/13 at 1:00 p.m.
2017-02-09HouseFirst Reading Health and Government Operations

Subjects


Maryland State Sources


Bill Comments

feedback